Mysore/Mysuru: In a major breakthrough that can add as a powerful ammunition to the fight against COVID, a Mysuru-based drug development company has discovered a new drug against human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
SARS-CoV-2 viral multiplication within the cell mainly depends on RdRp, a key enzyme that is involved in the RNA synthesis, the core material in the virus. City-based DRM Innovations has developed an entirely new drug to kill the SARS-CoV-2 virus using Artificial Intelligence.
